Abortion Access In The High Court, Again | Katie Keith

This episode is brought to you by Semafor Healthcare.

Delivered weekly from David Lim, Semafor Healthcare connects the dots between decisions in government, business, and technology to reveal how they impact the future of healthcare. Each edition will provide the analysis you need to understand and stay ahead of a rapidly changing landscape. Subscribe for free.

Health Affairs Publishing’s Jeff Byers welcomes Georgetown University’s Katie Keith and Deputy Editor Chris Fleming back to the podcast to unpack a new court case over mifepristone that could alter telehealth access to medication abortion and test the boundaries of FDA authority.

Join us on June 23 for an exclusive Insider virtual event examining how antitrust policy in health care is evolving at both the federal and state levels, featuring insights from Katherine Gudiksen, Leemore Dafny, and Nathan Hostert.

Related Links:

• Supreme Court Temporarily Blocks Ruling Barring Telehealth And Pharmacy Access To Mifepristone (Health Affairs Forefront)
• The US Food and Drug Administration’s Regulation of Mifepristone (JAMA)

Sign up for Health Affairs' free newsletter to catch up on our new articles, podcasts, and events.

Subscribe to Semafor Healthcare for free.